189 related articles for article (PubMed ID: 32564458)
1. The recurrence and progression risk after simultaneous endoscopic surgery of urothelial bladder tumour and benign prostatic hyperplasia: a systematic review and meta-analysis.
Sari Motlagh R; Mori K; Miura N; Quhal F; Aydh A; Laukhtina E; Pradere B; Karakiewicz PI; Enikeev DV; Deuker M; Shariat SF
BJU Int; 2021 Feb; 127(2):143-152. PubMed ID: 32564458
[TBL] [Abstract][Full Text] [Related]
2. Tumor recurrence in prostatic urethra following simultaneous resection of bladder tumor and prostate: a comparative retrospective study.
Jaidane M; Bouicha T; Slama A; Hmida W; Hidoussi A; Ben Sorba N; Mosbah F
Urology; 2010 Jun; 75(6):1392-5. PubMed ID: 19781747
[TBL] [Abstract][Full Text] [Related]
3. Assessment of the clinical efficacy of simultaneous transurethral resection of both bladder cancer and the prostate: a systematic review and meta-analysis.
Zhou L; Liang X; Zhang K
Aging Male; 2020 Dec; 23(5):1182-1193. PubMed ID: 32020826
[TBL] [Abstract][Full Text] [Related]
4. Oncological and safety profiles in patients undergoing simultaneous transurethral resection (TUR) of bladder tumour and TUR of the prostate.
Laukhtina E; Moschini M; Krajewski W; Teoh JY; Ploussard G; Soria F; Roghmann F; Muenker MA; Roumiguie M; Alvarez-Maestro M; Misrai V; Antonelli A; Tafuri A; Simone G; Mastroianni R; Zhao H; Rahota RG; D'Andrea D; Mori K; Albisinni S; Karakiewicz PI; Fajkovic H; Enikeev D; Montorsi F; Shariat SF; Pradere B;
BJU Int; 2023 May; 131(5):571-580. PubMed ID: 36134575
[TBL] [Abstract][Full Text] [Related]
5. Is it oncologically safe performing simultaneous transurethral resection of the bladder and prostate? A meta-analysis on 1,234 patients.
Picozzi SC; Ricci C; Gaeta M; Casellato S; Bozzini G; Ratti D; Carmignani L
Int Urol Nephrol; 2012 Oct; 44(5):1325-33. PubMed ID: 22710969
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous transurethral resection of bladder tumour and prostate: is it safe?
Kouriefs C; Loizides S; Mufti G
Urol Int; 2008; 81(2):125-8. PubMed ID: 18758207
[TBL] [Abstract][Full Text] [Related]
7. Oncological safety and quality of life in men undergoing simultaneous transurethral resection of bladder tumor and prostate: results from a randomized controlled trial.
Dellabella M; Branchi A; Gasparri L; Claudini R; Castellani D
World J Urol; 2018 Oct; 36(10):1629-1634. PubMed ID: 29725805
[TBL] [Abstract][Full Text] [Related]
8. [The risk of bladder cancer in patients with prostatic hyperplasia and strategies to manage this combination].
Alyaev YG; Pshikhachev AM; Perekalina AN
Urologiia; 2016 Nov; (5):115-118. PubMed ID: 28248032
[TBL] [Abstract][Full Text] [Related]
9. Does simultaneous transurethral resection of bladder tumor and prostate affect the recurrence of bladder tumor? A meta-analysis.
Luo S; Lin Y; Zhang W
J Endourol; 2011 Feb; 25(2):291-6. PubMed ID: 20977373
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous transurethral resection of bladder tumor and benign prostatic hyperplasia: hazardous or a safe timesaver?
Tsivian A; Shtricker A; Sidi AA
J Urol; 2003 Dec; 170(6 Pt 1):2241-3. PubMed ID: 14634388
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous transurethral resection of bladder cancer and prostate may reduce recurrence rates: A systematic review and meta-analysis.
Li S; Zeng XT; Ruan XL; Wang XH; Guo Y; Yang ZH
Exp Ther Med; 2012 Oct; 4(4):685-692. PubMed ID: 23170127
[TBL] [Abstract][Full Text] [Related]
12. Impact of enhanced optical techniques at time of transurethral resection of bladder tumour, with or without single immediate intravesical chemotherapy, on recurrence rate of non-muscle-invasive bladder cancer: a systematic review and network meta-analysis of randomized trials.
Sari Motlagh R; Mori K; Laukhtina E; Aydh A; Katayama S; Grossmann NC; Mostafai H; Pradere B; Quhal F; Schuettfort VM; Roshandel MR; Karakiewicz PI; Teoh J; Shariat SF; Fajkovic H
BJU Int; 2021 Sep; 128(3):280-289. PubMed ID: 33683778
[TBL] [Abstract][Full Text] [Related]
13. [One-stage transurethral resection of the urinary bladder and the prostate in patients with superficial cancer of the urinary bladder combined with benign prostatic hyperplasia].
Karaguzhin SG; Merinov DS; Martov AG
Urologiia; 2005; (5):17-21. PubMed ID: 16281833
[TBL] [Abstract][Full Text] [Related]
14. Effects of simultaneous transurethral resection of prostate and solitary bladder tumors smaller than 3 cm on oncologic results.
Ugurlu O; Gonulalan U; Adsan O; Kosan M; Oztekin V; Cetinkaya M
Urology; 2007 Jul; 70(1):55-9. PubMed ID: 17656208
[TBL] [Abstract][Full Text] [Related]
15. Real-life Experience: Early Recurrence With Hexvix Photodynamic Diagnosis-assisted Transurethral Resection of Bladder Tumour vs Good-quality White Light TURBT in New Non-muscle-invasive Bladder Cancer.
Mariappan P; Rai B; El-Mokadem I; Anderson CH; Lee H; Stewart S; Donat R
Urology; 2015 Aug; 86(2):327-31. PubMed ID: 26142924
[TBL] [Abstract][Full Text] [Related]
16. Concomitant Endoscopic Surgery for Bladder Tumors and Prostatic Obstruction: Are We Safely Hitting Two Birds with One Stone? A Systematic Review and Meta-Analysis.
Savvides E; Pyrgidis N; Langas G; Symeonidis EN; Dimitriadis G; Sountoulides P
J Clin Med; 2022 Oct; 11(20):. PubMed ID: 36294528
[TBL] [Abstract][Full Text] [Related]
17. Blue vs white light for transurethral resection of non-muscle-invasive bladder cancer: an abridged Cochrane Review.
Maisch P; Koziarz A; Vajgrt J; Narayan V; Kim MH; Dahm P
BJU Int; 2022 Dec; 130(6):730-740. PubMed ID: 35238145
[TBL] [Abstract][Full Text] [Related]
18. [Simultaneous treatment for benign prostate hyperplasia and its concomitant diseases].
Chong T; Li YQ; Wang ZM; Shi T; Zhang P
Zhonghua Nan Ke Xue; 2006 Jun; 12(6):534-6. PubMed ID: 16833196
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of bipolar versus monopolar transurethral resection of bladder tumors: A meta-analysis of randomized controlled trials.
Ma Y; Sun L; Lin X; Zhang W; Wang D
J Cancer Res Ther; 2020; 16(7):1588-1595. PubMed ID: 33565504
[TBL] [Abstract][Full Text] [Related]
20. Feasibility of holmium laser enucleation of the prostate (HoLEP) for recurrent/residual benign prostatic hyperplasia (BPH).
Elshal AM; Elmansy HM; Elhilali MM
BJU Int; 2012 Dec; 110(11 Pt C):E845-50. PubMed ID: 22702908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
